US Stock MarketDetailed Quotes
CMND Clearmind Medicine
- 2.2200
- +0.5200+30.59%
Close Jul 15 16:00 ET
- 2.1300
- -0.0900-4.05%
Pre 07:54 ET
7.35MMarket Cap-566P/E (TTM)
2.3000High1.7300Low3.01MVolume1.7300Open1.7000Pre Close6.20MTurnover92.52%Turnover RatioLossP/E (Static)3.31MShares16.194052wk High1.58P/B7.23MFloat Cap0.920552wk Low--Dividend TTM3.26MShs Float183.0000Historical High--Div YieldTTM33.53%Amplitude0.9205Historical Low2.0580Avg Price1Lot Size
Clearmind Medicine Stock Forum
Sign in to post a comment
$SciSparc(SPRC.US$ Same exact news as $Clearmind Medicine(CMND.US$ And two totally different reactions! Hehehe![]()
1
6
$Clearmind Medicine(CMND.US$ first time i see a negative move so quickly on premarket
$Clearmind Medicine(CMND.US$ Hehehe! as usual! 90% of the time when this moves it’s immediately shorted! Grrr![]()
$Clearmind Medicine(CMND.US$ Reuters· 2 mins ago
Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-Loss
Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-Loss
1
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference.
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotechnology firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has announced its participation in the forthcoming Psychedelic Medicine – Israel 2024 conference. This event will be he...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotechnology firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has announced its participation in the forthcoming Psychedelic Medicine – Israel 2024 conference. This event will be he...
1
$Clearmind Medicine(CMND.US$ finally after half month！！
1
$Clearmind Medicine(CMND.US$ when? any specific day?
$Clearmind Medicine(CMND.US$
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
Clearmind Medicine (Nasdaq: CMND), a clinical-stage biotech firm, will present significant research at the Psychedelic Medicine – Israel 2024 conference in Tel Aviv from July 28-30. CEO Adi Zullof-Shani, Ph.D., will discuss the potential of 5-Methoxy-2-Aminoindane (MEAI) as a regulator of binge behaviors on July 29. Additionally, researchers Prof. Joseph Tam an...
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
Clearmind Medicine (Nasdaq: CMND), a clinical-stage biotech firm, will present significant research at the Psychedelic Medicine – Israel 2024 conference in Tel Aviv from July 28-30. CEO Adi Zullof-Shani, Ph.D., will discuss the potential of 5-Methoxy-2-Aminoindane (MEAI) as a regulator of binge behaviors on July 29. Additionally, researchers Prof. Joseph Tam an...
3
$Clearmind Medicine(CMND.US$
I'm looking forward to tomorrow
I'm looking forward to tomorrow
3
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
102611832 : sold at 1.45.
TrytosaveabitOP 102611832: That’s great! WTG.
包小姐老公的养老金 : Gotta ask trytosaveabit for some teachings as a trader.
105045093jack : sigh, end up holding now from 1.35
105045093jack : sold for loss. didn't want to hold too long until it plunge to to centre of the earth.
View more comments...